コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 the glycogen-degrading lysosomal enzyme acid-alpha glucosidase.
2 also potent inhibitors of alpha-amylase and alpha-glucosidase.
3 ong natural inhibitors for alpha-amylase and alpha-glucosidase.
4 -robinobioside as the strongest inhibitor of alpha-glucosidase.
5 s an NAD(+)- and metal ion-dependent phospho-alpha-glucosidase.
6 colonies on this medium due to production of alpha-glucosidase.
7 by a deficiency of the lysosomal enzyme acid alpha-glucosidase.
8 are good covalent inhibitors of a GH13 yeast alpha-glucosidase.
9 lic mechanism-based covalent inhibitor of an alpha-glucosidase.
10 docking predicted a high affinity of CGA for alpha-glucosidase.
11 when coincubated with the recombinant human alpha-glucosidase.
12 crog/ml) displayed strong inhibition towards alpha-glucosidase.
13 nt to the extensive digestion by the mucosal alpha-glucosidases.
14 e roles of individual and collective mucosal alpha-glucosidases.
15 identical, functions with other cloned human alpha-glucosidases.
16 J-based iminosugar derivatives to inhibit ER alpha-glucosidases.
17 does not inhibit endoplasmic reticulum (ER) alpha-glucosidases.
18 mmalian and yeast origin than to other plant alpha-glucosidases.
19 3 of the C-ring was related to inhibition of alpha-glucosidases.
20 f altered glycosylation after treatment with alpha-glucosidase-1 inhibitor, N-butyldeoxynojirimycin (
24 gainst enzymes with biological significance (alpha-glucosidase, acetylcholinesterase and butyrylcholi
25 his study was to investigate how the mucosal alpha-glucosidases act with alpha-amylase to digest gran
26 ir effect in inhibiting i) alpha-amylase and alpha-glucosidase activities and ii) colorectal cancer c
27 g a combination of alpha-amylase and mucosal alpha-glucosidase activities, were applied to three gran
31 6pc(-/-) mice, pharmacological inhibition of alpha-glucosidase activity almost completely abolished r
32 ome monoterpenes inhibited alpha-amylase and alpha-glucosidase activity and stimulated glucose uptake
33 se-related changes in glycogen, glucose, and alpha-glucosidase activity are also found in spinal cord
39 gene, resulting in deficient lysosomal acid-alpha-glucosidase activity in patients, and a progressiv
42 a-D-glucopyranoside revealed that the acidic alpha-glucosidase activity is predominantly located in t
43 le blood-based assay to measure the level of alpha-glucosidase activity is the optimal initial test f
44 n-regulated in the expression of MAL1, total alpha-glucosidase activity was not decreased in leaves a
45 Differential inhibition of alpha-amylase and alpha-glucosidase activity was observed in response to p
47 has the strongest inhibitory effect against alpha-glucosidase activity with IC(50) 0.08 +/- 0.002 mg
49 he function of a potato gene (MAL1) encoding alpha-glucosidase activity, transgenic plants in which M
50 sorghum and rye extracts inhibited (p<0.05) alpha-glucosidase activity, whereas barley and sorghum e
51 e activities of the three lysosomal enzymes (alpha-glucosidase (AG), beta-galactosidase (B-GAL) and b
55 llular dehydrogenase (DHA) and extracellular alpha-glucosidase (alpha-Glu) and protease (PRO) enzymes
56 nd phytoprostanes (PhytoPs) on four enzymes: alpha-glucosidase, alpha-amylase, acetylcholinesterase,
59 ssociated with metabolic syndrome, including alpha-glucosidase, amylase and lipase and exhibited anti
60 hysiological relevance of acid maltase (acid alpha-glucosidase, an enzyme that degrades lysosomal gly
62 d (150 rpm), significantly (p < 0.05) higher alpha-glucosidase and acetylcholinesterase inhibition ac
63 ntioxidant activities for free fraction, and alpha-glucosidase and acetylcholinesterase inhibition fo
64 dical scavenging activity and alpha-amylase, alpha-glucosidase and aldose reductase inhibitory activi
65 nds and the inhibitory effect of extracts on alpha-glucosidase and alpha-amylase activities were inve
69 ong with evaluation of in vitro antioxidant, alpha-glucosidase and alpha-amylase inhibitory activitie
70 of Verdolino extracts exhibited the highest alpha-glucosidase and alpha-amylase inhibitory activity
71 , which can be counteracted by inhibition of alpha-glucosidase and alpha-amylase, both involved in th
72 strong antioxidant activities, inhibition of alpha-glucosidase and alpha-amylase, inhibition of angio
77 wed the highest inhibition of alpha-amylase, alpha-glucosidase and lipase (IC50: 0.38mg/mL, 0.87mug/m
78 ced LDL-cholesterol peroxidation, as well as alpha-glucosidase and lipase activities were demonstrate
81 daria pinnatifida has a potential to inhibit alpha-glucosidase and may be used as a bioactive food in
82 the deficiency of the lysosomal enzyme acid alpha-glucosidase and results in cellular lysosomal and
87 sults for hSGLT3 are compared with those for alpha-glucosidases and human SGLT type 1 (hSGLT1), a wel
89 ng-alkyl-chain DNJ derivatives to inhibit ER alpha-glucosidases and their antiviral effect, ruling ou
90 oxidant activity, and greater alpha-amylase, alpha-glucosidase, and ACE inhibitory activity than the
91 trong inhibitory potential of alpha-amylase, alpha-glucosidase, and dipeptidyl peptidase III (DPP III
92 was distinct for antioxidant activity, ACE-, alpha-glucosidase-, and Kunitz trypsin-inhibitory activi
93 . meliloti possesses at least one additional alpha-glucosidase as well as a lower-affinity transport
95 act showed promising results as inhibitor of alpha-glucosidase, being almost 9 times more effective t
97 ing characteristics are similar to those for alpha-glucosidases, but there are no interactions with h
99 loned human alpha-glucosidase (human neutral alpha-glucosidase C or GANC) is a previously uncharacter
102 eolysis of intact viral capsid proteins, the alpha-glucosidase-catalyzed hydrolysis of p-nitrophenyl-
104 ase (PD) is a metabolic myopathy due to acid alpha-glucosidase deficiency and characterized by extens
105 ical cloning of two alleles of human neutral alpha-glucosidase (designated GANC on the human gene map
106 PR-mediated uptake of recombinant human acid-alpha-glucosidase during ERT in mice with Pompe disease
109 uorogenic substrate is a useful tool for the alpha-glucosidase enzyme assay and will facilitate compo
110 eveloped a new fluorogenic substrate for the alpha-glucosidase enzyme assay, resorufin alpha-d-glucop
111 racts showed more than 80% inhibition of the alpha-glucosidase enzyme at a concentration of 40mg/mL (
113 UV-4B is an iminosugar that inhibits the alpha-glucosidase family of enzymes and subsequently the
114 he unique and shared roles of the individual alpha-glucosidases for alpha-glucans persisting after st
115 s the most potent (IC50: 0.25mug/mL) against alpha-glucosidase; Fraction IV from black turtle bean wa
116 nment with its homologs, the novel 6-phospho-alpha-glucosidase from B. subtilis can be assigned to th
117 found to be low micromolar inhibitors of the alpha-glucosidase from baker's yeast with Ki's near to 2
119 and the enzymatic activity of a recombinant alpha-glucosidase from human gut bacterium Ruminococcus
120 utation in the active site of the homologous alpha-glucosidase from Sulfolobus solfataricus resulted
121 ly, we also found that, unlike mammals, acid alpha-glucosidase from zebrafish and medaka does not app
122 the glycogen-degrading lysosomal enzyme acid alpha -glucosidase (GAA) (also called "acid maltase"), c
123 bolic disorder characterized by lack of acid-alpha glucosidase (GAA) resulting in ubiquitous lysosoma
124 f lysosomal glycogen-hydrolyzing enzyme acid alpha-glucosidase (GAA) activity, which results in lysos
126 s primarily the liver and kidney, while acid alpha-glucosidase (GAA) deficiency in GSD II causes prim
127 Enzyme or gene replacement therapy with acid alpha-glucosidase (GAA) has achieved only partial effica
128 sported to and degraded in lysosomes by acid alpha-glucosidase (GAA) in mammals, but it is unclear wh
131 of a modified Ad vector encoding human acid alpha-glucosidase (GAA) resulted in efficient hepatic tr
132 erated by treating the lysosomal enzyme acid alpha-glucosidase (GAA) with recombinant GlcNAc-phosphot
133 e II (GSDII), caused by a deficiency in acid alpha-glucosidase (GAA), leads to lysosomal accumulation
134 IOPD), caused by mutations in lysosomal acid alpha-glucosidase (Gaa), manifests rapidly progressive f
135 cardiomyopathy caused by deficiency of acid alpha-glucosidase (GAA), skeletal muscle seems an obviou
136 system to improve lysosomal delivery of acid alpha-glucosidase (GAA), the enzyme deficient in patient
137 s directly related to the deficiency of acid alpha-glucosidase (GAA), which degrades glycogen in the
138 esisted enzyme replacement therapy with acid alpha-glucosidase (GAA), which has been attributed to in
143 expression and regulation of the human acid alpha-glucosidase gene as well as other lysosomal enzyme
144 previously demonstrated that the human acid alpha-glucosidase gene expression is regulated by a sile
145 steady-state expression level of the potato alpha-glucosidase gene was low in most tissues examined,
147 -center structure with that of the 6-phospho-alpha-glucosidase GlvA from Bacillus subtilis reveals a
149 ements confirmed their high affinity towards alpha-glucosidase, highlighting a static quenching mecha
150 e hypothesized that an as-yet uncloned human alpha-glucosidase (human neutral alpha-glucosidase C or
151 wo siblings with a rare genetic defect in ER alpha-glucosidase I (ER Glu I) who showed resistance to
153 pha-glucosidase I may have a small amount of alpha-glucosidase I activity in vivo based on the low le
154 Chinese hamster ovary cells are defective in alpha-glucosidase I activity, which removes the distal a
156 omimetic that inhibits endoplasmic reticulum alpha-glucosidase I and II enzymes resulting in improper
158 charide glucosidase (OsMOGS), an ortholog of alpha-glucosidase I in Arabidopsis, which trims the term
160 of knf embryos demonstrated that KNF encodes alpha-glucosidase I, the enzyme that catalyzes the first
161 xtract was particularly active against yeast alpha-glucosidase (IC(50) = 1.53 mug/mL), acting through
162 bsorbance capacity and effectively inhibited alpha-glucosidase (IC(50): 0.83 mg/ml) and pancreatic li
163 hibition (alpha-amylase: IC(50)-42.34 ug/mL; alpha-glucosidase: IC(50):63.89 ug/mL), basal uptake of
164 chickpea showed inhibitory activity against alpha-glucosidase (IC50 6967 +/- 343 and 2885 +/- 85.4 m
165 mug/ml (bran) and 148.23 mug/ml (hulls)] and alpha-glucosidase [IC50, 62.1 mug/ml (bran) and 68.14 mu
166 ystal structures of the main ERQC enzyme, ER alpha-glucosidase II (alpha-GluII; from mouse), alone an
167 more similar to the glycoprotein-processing alpha-glucosidase II of mammalian and yeast origin than
168 , as well as a decrease in the inhibition of alpha-glucosidase in both extracts, when compared to und
172 alpha-Amylase combined with the mucosal alpha-glucosidases in the intestinal extract showed high
173 d pancreatic alpha-amylases and four mucosal alpha-glucosidases, including N- and C-terminal subunits
174 vefold range of dietary NSP intake, although alpha-glucosidase increased on a resistant starch-enrich
175 N-terminal sequence from the 96-kD broccoli alpha-glucosidase indicated that it corresponds to the A
176 iated uptake because alpha-l-iduronidase and alpha-glucosidase induced tolerance with the drug regime
177 iched in tannins (16C) induced a more potent alpha-glucosidase inhibition (pIC(50) = 5.3 +/- 0.1).
178 nce regarding the in vitro alpha-amylase and alpha-glucosidase inhibition activities of extracts deri
179 parameters that affect the alpha-amylase and alpha-glucosidase inhibition activities of the extracts.
183 m of this study was to evaluate the in vitro alpha-glucosidase inhibition and antioxidant activity of
184 m of this study was to evaluate the in vitro alpha-glucosidase inhibition and antioxidant activity of
186 radical scavenging, beta-carotene bleaching, alpha-glucosidase inhibition and greatest amount of TPC.
187 cavenging, beta-carotene bleaching activity, alpha-glucosidase inhibition and the highest total pheno
188 es and their antiviral effect, ruling out ER alpha-glucosidase inhibition as the sole mechanism respo
189 d acetone extracts of seaweeds were used for alpha-glucosidase inhibition assay hyphenated with high
190 alytical platform based on a high-resolution alpha-glucosidase inhibition assay in combination with h
191 multivariate data analysis, high-resolution alpha-glucosidase inhibition assays and HPLC-HRMS-SPE-NM
192 anol extract of H. biflora (HBMe) showed 50% alpha-glucosidase inhibition at the concentration of 480
195 rthermore investigated using high-resolution alpha-glucosidase inhibition profiling combined with hig
196 bition) activity, however, a 10% increase in alpha-glucosidase inhibition was observed in irradiated
199 observed on antidiabetic (alpha-amylase and alpha-glucosidase inhibition) activity, however, a 10% i
200 fits (anticancer activity, alpha-amylase and alpha-glucosidase inhibition, angiotensin-converting-enz
201 s investigated, as well as alpha-amylase and alpha-glucosidase inhibition, antihypertensive, antioxid
203 on nullified roasting-induced differences in alpha-glucosidase inhibition, CGA showed a decreasing tr
204 brews were in vitro digested and tested for alpha-glucosidase inhibition, to explore their antidiabe
207 Water fraction (WF) of ME was a stronger alpha-glucosidase inhibitor (EC50 2.9 mug/mL) than querc
208 itor (SMD, 0.33 [95% CI, 0.13 to 0.52]), and alpha-glucosidase inhibitor (SMD, 0.35 [95% CI, 0.12 to
210 oselective synthesis of nectrisine, a potent alpha-glucosidase inhibitor, was carried out starting fr
213 therapeutic target for type II diabetes, and alpha-glucosidase inhibitors have been used in the clini
216 antioselective total synthesis of the potent alpha-glucosidase inhibitors schulzeine A, B, and C and
218 these phenolic sub-classes were more potent alpha-glucosidase inhibitors than the clinical drug, aca
219 7-2.08 kg), glucagon-like peptide-1 analogs, alpha-glucosidase inhibitors, and dipeptidyl peptidase-4
220 , more expensive agents (thiazolidinediones, alpha-glucosidase inhibitors, and meglitinides), older a
221 by structural identification targeted these alpha-glucosidase inhibitors, as demonstrated by a proof
222 sulins, sulfonylureas, glinides, biguanides, alpha-glucosidase inhibitors, thiazolidinediones, glucag
223 primarily by adding or adjusting metformin, alpha-glucosidase inhibitors, thiazolidinediones, or ins
228 C50 values following fermentation, while the alpha-glucosidase inhibitory activities ranged from 95.2
231 ion of X2C gave a subfraction, with enhanced alpha-glucosidase inhibitory activity (IC50=6.15mug/mL),
232 HR-bioassay/HPLC-HRMS-SPE-NMR showed the alpha-glucosidase inhibitory activity of A. nodosum, F.
234 ebaudioside-A showed concentration-dependent alpha-glucosidase inhibitory activity with IC50=35.01 mu
235 d fast identification of three analytes with alpha-glucosidase inhibitory activity, and subsequent HP
240 atform enables fast screening for individual alpha-glucosidase inhibitory analytes in complex matrice
241 plausibly due to the presence of intestinal alpha-glucosidase inhibitory and augmenting cellular glu
243 strated stronger antioxidant activity and an alpha-glucosidase inhibitory property than positive cont
244 le and lemon myrtle fractions had pronounced alpha-glucosidase-inhibitory activities (IC(50): 0.30 an
247 e 2 diabetes framework, the extract inhibits alpha-glucosidase (K(i) = 166.9 ug/mL) and aldose reduct
248 a6/Delta6), like the recently published acid alpha-glucosidase knockout with disruption of exon 13, h
251 metabolic syndrome, including alpha-amylase, alpha-glucosidase, lipase and hydroxyl methyl glutaryl C
252 The specific activities of three enzymes, an alpha-glucosidase (malA), a beta-glycosidase (lacS), and
253 s of three glycosyl hydrolases, including an alpha-glucosidase (malA), a beta-glycosidase (lacS), and
254 nolic compounds did not affect inhibition of alpha-glucosidase (maltase) activity, which remained rel
255 in turn hydrolyzed to glucose by the mucosal alpha-glucosidases, maltase-glucoamylase (MGAM) and sucr
257 ith flaviviruses (for example, V-ATPases and alpha-glucosidases), most of the DVHFs were newly implic
261 capacities and inhibitory activities against alpha-glucosidase, pancreatic lipase and angiotensin I-c
262 extract and its inhibiting activity against alpha-glucosidase, pancreatic lipase and hyaluronidase w
263 tion, enzymatic in vitro inhibition tests of alpha-glucosidase, pancreatic lipase, acetylcholinestera
264 terase), anti-diabetic (anti-alpha-amylase, -alpha-glucosidase, -pancreatic lipase) and antioxidant p
265 he ethyl acetate fraction inhibited in vitro alpha-glucosidase (pIC(50) = 4.8 +/- 0.1), an enzyme inv
266 vels of the full-length GAA transcript, acid-alpha-glucosidase protein, and enzyme activity in all pa
269 ose 6-phosphate hydrolase) and pagl (phospho-alpha-glucosidase), respectively, reside in separate ope
270 atively high doses of recombinant human acid alpha-glucosidase (rhGAA) may be required to reduce the
271 idase, and the 1-nonylazetidine 25 inhibited alpha-glucosidase (Saccharomyces cerevisiae) with an IC(
273 s of alpha-amylase, but potent inhibitors of alpha-glucosidase, showing low-micromolar IC(50) values,
274 ibition properties against alpha-amylase and alpha-glucosidases, showing different inhibition constan
275 via their ability to inhibit alpha-amylase, alpha-glucosidase, sodium-glucose transporters, and panc
278 se (SI) is an intestinal membrane-associated alpha-glucosidase that breaks down di- and oligosacchari
279 lB is an unusual NAD+/Mn2+-dependent phospho-alpha-glucosidase that promotes growth of MG-1655 (pAP1)
280 , Mn2+, and dithiothreitol-dependent phospho-alpha-glucosidases that can be assigned to family 4 of t
281 copyranosyl:phosphoglucohydrolase (6-phospho-alpha-glucosidase) that requires both NAD(H) and divalen
287 ular starch by mammalian recombinant mucosal alpha-glucosidases was observed which shows that these e
289 nd lysosomal acid maltase, two major hepatic alpha-glucosidases, were unaltered in L-G6pc(-/-) mice,
290 ese residues were not acquired on human acid alpha-glucosidase when expressed in zebrafish embryos, s
291 y measuring its activation by an ER resident alpha-glucosidase, which is dependent on entry into the
292 P generated uncompetitive inhibitors against alpha-glucosidase, while EAEP, AEP, and HEX-AEP (used as
293 system, and one (aglA) appears to encode an alpha-glucosidase with homology to family 13 of glycosyl
294 ample of fucoxanthin significantly inhibited alpha-glucosidase with IC(50) value 0.047 +/- 0.001 mg/m
295 from black currant and rowanberry, inhibited alpha-glucosidase with IC(50) values respectively of 20
296 nnaeus were found to be potent inhibitors of alpha-glucosidase with IC50 values of 0.32 and 0.49 mug/
297 s were found to be potent inhibitors of rice alpha-glucosidase with K(i) and IC(50) values in the nan
298 ysosomal enzymes alpha-l-iduronidase or acid alpha-glucosidase with the receptor-associated protein w
299 two commercial samples were able to inhibit alpha-glucosidase, with EC(50) values lower than that fo
300 Fractions X1C and X2C notably inhibited alpha-glucosidase, with IC50=9.89 and 8.05mug/mL, respec